Fig. 1: Participant flow in the study of repeated-dose intravenous ketamine for depression. | Translational Psychiatry

Fig. 1: Participant flow in the study of repeated-dose intravenous ketamine for depression.

From: Non-improvement predicts subsequent non-response to repeated-dose intravenous ketamine for depression: a re-analysis of a 2-week open-label study in patients with unipolar and bipolar depression

Fig. 1

A total of 257 patients were assessed for eligibility. One hundred and thirty-five patients met inclusion criteria and received ketamine treatment, with 117 patients completing the six infusions. Ultimately, data from these 117 patients were included in the analysis.

Back to article page